Raghda E. Eldesouki

417 total citations
16 papers, 200 citations indexed

About

Raghda E. Eldesouki is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Raghda E. Eldesouki has authored 16 papers receiving a total of 200 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 2 papers in Molecular Biology and 2 papers in Epidemiology. Recurrent topics in Raghda E. Eldesouki's work include SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (7 papers) and SARS-CoV-2 detection and testing (5 papers). Raghda E. Eldesouki is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (7 papers) and SARS-CoV-2 detection and testing (5 papers). Raghda E. Eldesouki collaborates with scholars based in Egypt, United States and Saudi Arabia. Raghda E. Eldesouki's co-authors include Heba H. Mostafa, Julie M. Norton, Amary Fall, Eili Klein, C. Paul Morris, Michael Forman, David C. Gaston, Nicholas Gallagher, Andrew Pekosz and Maggie Li and has published in prestigious journals such as Clinical Infectious Diseases, Frontiers in Pharmacology and EBioMedicine.

In The Last Decade

Raghda E. Eldesouki

13 papers receiving 196 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Raghda E. Eldesouki Egypt	8	141	42	31	23	22	16	200
Silvia Fabris Italy	7	139 1.0×	21 0.5×	48 1.5×	5 0.2×	6 0.3×	18	243
Kaori Okayama Japan	9	102 0.7×	163 3.9×	62 2.0×	17 0.7×	12 0.5×	38	287
Il‐Hwan Kim South Korea	9	126 0.9×	27 0.6×	29 0.9×	6 0.3×	3 0.1×	28	171
Mina Mobini Kesheh Iran	9	151 1.1×	112 2.7×	75 2.4×	9 0.4×	3 0.1×	16	305
Yuki Miyajima Japan	9	244 1.7×	53 1.3×	41 1.3×	4 0.2×	4 0.2×	22	314
Amal H. Alfaraj Saudi Arabia	6	86 0.6×	22 0.5×	33 1.1×	6 0.3×	6 0.3×	8	138
Hamda Khansaheb United Arab Emirates	7	147 1.0×	43 1.0×	29 0.9×	2 0.1×	6 0.3×	17	207
Asmita Gupte United States	7	174 1.2×	104 2.5×	41 1.3×	10 0.4×	12 0.5×	13	268
Ilona Kronig Switzerland	6	326 2.3×	51 1.2×	73 2.4×	9 0.4×	3 0.1×	6	378
Antonino Salvia Italy	7	150 1.1×	18 0.4×	38 1.2×	3 0.1×	3 0.1×	13	197

Countries citing papers authored by Raghda E. Eldesouki

Since Specialization

Citations

This map shows the geographic impact of Raghda E. Eldesouki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raghda E. Eldesouki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raghda E. Eldesouki more than expected).

Fields of papers citing papers by Raghda E. Eldesouki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raghda E. Eldesouki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raghda E. Eldesouki. The network helps show where Raghda E. Eldesouki may publish in the future.

Co-authorship network of co-authors of Raghda E. Eldesouki

This figure shows the co-authorship network connecting the top 25 collaborators of Raghda E. Eldesouki. A scholar is included among the top collaborators of Raghda E. Eldesouki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raghda E. Eldesouki. Raghda E. Eldesouki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Singh, Manisha, et al.. (2025). FDA-approved drug repurposing screen identifies inhibitors of SARS-CoV-2 pseudovirus entry. Frontiers in Pharmacology. 16. 1537912–1537912.

Eldesouki, Raghda E., et al.. (2024). Association of IL-10–592 C > A /-1082 A > G and the TNFα -308 G > A with susceptibility to COVID-19 and clinical outcomes. BMC Medical Genomics. 17(1). 40–40. 1 indexed citations

Eldesouki, Raghda E., Jaiprasath Sachithanandham, Amary Fall, et al.. (2024). Reduced control of SARS-CoV-2 infection associates with lower mucosal antibody responses in pregnancy. mSphere. 9(3). e0081223–e0081223. 4 indexed citations

Fall, Amary, Julie M. Norton, Raghda E. Eldesouki, et al.. (2023). An increase in enterovirus D68 circulation and viral evolution during a period of increased influenza like illness, The Johns Hopkins Health System, USA, 2022. Journal of Clinical Virology. 160. 105379–105379. 17 indexed citations

Klein, Eili, et al.. (2023). Severity outcomes associated with SARS-CoV-2 XBB variants, an observational analysis. Journal of Clinical Virology. 165. 105500–105500. 14 indexed citations

Robinson, Matthew L., C. Paul Morris, Joshua Betz, et al.. (2022). Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Variants on Inpatient Clinical Outcome. Clinical Infectious Diseases. 76(9). 1539–1549. 17 indexed citations

Morris, C. Paul, Raghda E. Eldesouki, Jaiprasath Sachithanandham, et al.. (2022). Omicron Subvariants: Clinical, Laboratory, and Cell Culture Characterization. Clinical Infectious Diseases. 76(7). 1276–1284. 9 indexed citations

Eldesouki, Raghda E., et al.. (2022). The circulation of Non-SARS-CoV-2 respiratory viruses and coinfections with SARS-CoV-2 during the surge of the Omicron variant. Journal of Clinical Virology. 153. 105215–105215. 11 indexed citations

Fall, Amary, Raghda E. Eldesouki, Jaiprasath Sachithanandham, et al.. (2022). The displacement of the SARS-CoV-2 variant Delta with Omicron: An investigation of hospital admissions and upper respiratory viral loads. EBioMedicine. 79. 104008–104008. 76 indexed citations

10.

Morris, C. Paul, Raghda E. Eldesouki, Amary Fall, et al.. (2022). SARS-CoV-2 reinfections during the Delta and Omicron waves. JCI Insight. 7(20). 6 indexed citations

11.

Eldesouki, Raghda E., Chengxiang Wu, Fayez M. Saleh, et al.. (2021). Identification and Targeting of Thomsen–Friedenreich and IL1RAP Antigens on Chronic Myeloid Leukemia Stem Cells Using Bi-Specific Antibodies. OncoTargets and Therapy. Volume 14. 609–621. 6 indexed citations

12.

Kishk, Rania, et al.. (2021). Prevalence of Aminoglycoside Resistance and Aminoglycoside Modifying Enzymes in Acinetobacter baumannii Among Intensive Care Unit Patients, Ismailia, Egypt. Infection and Drug Resistance. Volume 14. 143–150. 28 indexed citations

13.

Eldesouki, Raghda E.. (2021). Specific Language Impairment Genes, Variants and Possible Gene-based Interventions. 24(1). 1–11. 1 indexed citations

14.

Awad, Yasser M., et al.. (2020). The potential neuroprotective role ofAmphora coffeaeformisalgae against monosodium glutamate-induced neurotoxicity in adult albino rats. Food & Function. 12(2). 706–716. 10 indexed citations

15.

Kishk, Rania, et al.. (2020). Cytotoxic T Lymphocyte Antigen 4 Gene +49 A/G (rs231775) Polymorphism and Susceptibility to Systemic Lupus Erythematosus. Current Rheumatology Reviews. 17(2). 247–251.

16.

Hosny, Somaya, et al.. (2019). Application of Modified Team-Based Learning Approach for Enhancing Undergraduate Medical Educational Seminars. Medical Science Educator. 29(4). 1163–1170.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact